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cells/pL. Serum LDH and aminotransferase levels were 
normal. Treatment with AbelcetB (5 mg/kg daily) was 
initiated for bilateral Aspergillus furnigatus invasive 
pulmonary mycosis confirmed by CT scan and bronchial 
cultures. He showed significant improvement during 
2nd week and near-complete resolution of pulmonary 
densities on CT scan. Due to exacerbation of cutaneous 
and orointestinal tract GvHD, the patient was given 
therapy with equine anit-thymocyte globulin, tacrolimus, 
and high-dose methylprednisolone. The 3rd week was 
marked by recurrence of fever (>39”C), and several new 
upper lobe pulmonary lesions. Blood and bronchial 
samples were sterile. Abelcet@ dose was increased (7.5 
mg/kg daily), and oral itraconazole (400 mg liquid every 
8h) was initiated. On 24th day of hospitalization, he 
developed headache, 6th cranial nerve paralysis and 
unsteady wide-based gait. A superior vermian abnor- 
mality including intra-axial cerebellar lesion was noticed 
on magnetic resonance images of brain. Abelcet@ was 
increased to 10 mg/kg daily. He developed progressive 
weakness, obtundation, and died on hospital day 36. 
On postmortem examination a large necrotic abscess 
involving the cerebellar vermis that extended into 
posterior brain stem was seen. Branching, septate hyphal 
elements extending from cerebellar blood vessels were 
seen on histological examination, and S. apiospermum 
was isolated within 72 h. Antifungal susceptibility (MIC 
pg/ml) included: amphotericin B > 16.0; flucytosine 
>64.0; fluconazole 32.0; itraconazole 2.0; ketoconazole 
0.5; and voriconazole 0.5. Cerebellum tissue bioassay for 
free amphotericin B showed levels co.25 rJ,g/ml. 
Conclusions: Breakthrough invasive mycosis due to 
amphotericin B non-susceptible fungi is increasing. 
The newer broad-spectrum triazole-based agents with 
excellent central nervous penetration may significantly 
improve treatment options in patients at risk. 
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Blood stream infections (BSI) are a significant cause of 
morbidity and mortality among patients with cancer 
undergoing therapy. We evaluated all BSI which 
occurred in cancer patients at our institution during 
2000-01 in order to identify the causative pathogens. 
Nosocomial BSI was defined as symptoms and at 
least 2 positive blood cultures for coagulase-negative 
Staphylococcus (CONS) and other skin contaminants 
and one or more positive blood cultures for all other 
pathogens. 
A total of 399 episodes of BSI occurred in 273 patients. 
Of these patients hematological cancer (HC) was 
present in 104 and solid cancers (SC) in 169. Gram- 
positive pathogens were isolated in 221 (55%) of the 
BSI, gram-negatives in 161(40%) and candida spp. in 17 
(5%). Overall, the commonest pathogens isolated were 
S aureus 72 (18%) CONS 63 (16%) Klebsiella spp. 39 
(10%) E. coli 39 (10%) Enterococcus 33 (8%) 
Pseudomonas spp. 24 (6%) , viridans streptococci 22 (6%) 
Enterobacter spp. 18 (5%) Corynebacterium spp. 
11(3%), and S. pneumoniae 9 (2%). Among HC the 
predominant organisms were S aureus 20%) CONS 16%) 
Enterococcus 10%) Pseudomonas 9%, Klebsiella 7 % and 
S pneumoniae 3%. In SC the commonest organisms 
were S aureus 18%, CONS 16%, E.coli 14%, Klebsiella 
13 % , Enterococcus 7%) viridans streptococci 6 %, 
Candida 6%) and Pseudomonas 3%. Twenty-eight 
(27%) of the HC patients vs 29 (17%) of SC patients 
were neutropenic at the time of the BSI. In HC patients 
with neutropenia there were 41 episodes of BSI and the 
commonest organisms were Pseudomonas 17%, CONS 
17%, Enterococcus 12%, S. aureus 9%, Candida 7% and 
E. coli 7%. In contrast of the 34 episodes of BSI in SC 
patients with neutropenia the commonest organisms 
were E. coli 32%, Klebsiella 14%, S. aureus 12%, CONS 
9%, Pseudomonas 6%, and Acinetobacter 6%. 
Gram-positive pathogens were the commonest patho- 
gens isolated from BSI in cancer patients. However, 
the gram-negative pathogens such as E. coli, Klebsiella, 
and Pseudomonas are still significant causes of BSI 
especially among patients with neutropenia. Moreover, 
Pseudomonas still remains the most common pathogen 
isolated from BSI in HC patients with neutropenia. 
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Introduction: A clinical audit was carried out over 5 
years (1997-2001) in the immunocompromised patients 
including neutropenic patients and bone marrow 
(autograft) transplant recipients in hematology ward 
of Gartnaval General Hospital, Glasgow, a tertiary care 
center. 
Objective: It was aimed to establish the degree of 
correlation between bacterial isolates in oro-pharyngeal 
screen during bacteraemia episodes and role of anti- 
biotic prophylaxis. 
Methods: 2191 specimens from 255 patients with 
bacteraemia episodes were screened. 
Results: 29.4% (75/255) incidence of positive cor- 
relation, and 38.4% (981255) of negative correlation 
was observed. There was 32.1% (82/255) incidence of 
coagulase negative staphylococcus (CNS) bacteraemia. 
